tradingkey.logo

Work Medical Technology Group Ltd

WOK
3.450USD
-0.200-5.48%
Close 11/05, 16:00ETQuotes delayed by 15 min
50.34MMarket Cap
--P/E TTM

Work Medical Technology Group Ltd

3.450
-0.200-5.48%

More Details of Work Medical Technology Group Ltd Company

Work Medical Technology Group Ltd is a holding company mainly engaged in the manufacturing of medical devices. The Company's main products include medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, guedel airways, and other Class I disposable medical devices, disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kit, oxygen face masks, anesthesia masks, laryngoscope blades, yankauer suction sets, nasal oxygen cannulas, and other Class II disposable medical devices, KN95 masks, filtering half mask, and other medical devices, as well as medical innovative devices and equipment, such as visualized prostatic dilatation catheter. The Company principally conducts its businesses in domestic and overseas markets, such as Asia, Africa, Europe, North America, South America, and Oceania.

Work Medical Technology Group Ltd Info

Ticker SymbolWOK
Company nameWork Medical Technology Group Ltd
IPO dateAug 23, 2024
CEOMr. Shuang Wu
Number of employees229
Security typeOrdinary Share
Fiscal year-endAug 23
AddressBuilding 23, No. 2 Tonghuinan Rd., Xiaoshan District
CityHANGZHOU
Stock exchangeNASDAQ Capital Market Consolidated
CountryChina
Postal code311200
Phone8657182613568
Websitehttps://www.workmedtech.com/
Ticker SymbolWOK
IPO dateAug 23, 2024
CEOMr. Shuang Wu

Company Executives of Work Medical Technology Group Ltd

Name
Name/Position
Position
Shareholding
Change
Mr. Xiaoyang Li
Mr. Xiaoyang Li
Independent Director
Independent Director
--
--
Mr. Zhongxuan Li
Mr. Zhongxuan Li
Independent Director
Independent Director
--
--
Mr. Shuang Wu
Mr. Shuang Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Ningfang Liang
Mr. Ningfang Liang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Baiming Yu
Mr. Baiming Yu
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Robert Johnson
Mr. Robert Johnson
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Xiaoyang Li
Mr. Xiaoyang Li
Independent Director
Independent Director
--
--
Mr. Zhongxuan Li
Mr. Zhongxuan Li
Independent Director
Independent Director
--
--
Mr. Shuang Wu
Mr. Shuang Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Ningfang Liang
Mr. Ningfang Liang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Baiming Yu
Mr. Baiming Yu
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Robert Johnson
Mr. Robert Johnson
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2023
FY2022
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Others
13.72M
0.00%
Medical devices other than masks
8.00M
58.95%
Marks
5.09M
37.53%
Commodity trading
325.43K
2.40%
By RegionUSD
Name
Revenue
Proportion
China
12.60M
92.87%
Overseas market
967.69K
7.13%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Others
13.72M
0.00%
Medical devices other than masks
8.00M
58.95%
Marks
5.09M
37.53%
Commodity trading
325.43K
2.40%

Shareholding Stats

Updated: Tue, Oct 7
Updated: Tue, Oct 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
L1 Capital Global Opportunities Master Fund Ltd.
8.23%
LWY GROUP LTD
6.51%
UBS Financial Services, Inc.
0.05%
Citadel Advisors LLC
0.03%
Susquehanna International Group, LLP
0.01%
Other
85.17%
Shareholders
Shareholders
Proportion
L1 Capital Global Opportunities Master Fund Ltd.
8.23%
LWY GROUP LTD
6.51%
UBS Financial Services, Inc.
0.05%
Citadel Advisors LLC
0.03%
Susquehanna International Group, LLP
0.01%
Other
85.17%
Shareholder Types
Shareholders
Proportion
Corporation
14.74%
Investment Advisor
0.07%
Hedge Fund
0.03%
Other
85.17%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
9
79.91K
8.32%
+78.09K
2025Q2
8
6.35M
12.98%
-18.36K
2025Q1
8
6.35M
37.37%
-18.36K
2024Q4
14
12.62M
86.49%
+6.36M
2024Q3
10
12.51M
85.72%
+12.51M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
L1 Capital Global Opportunities Master Fund Ltd.
7.90M
8.23%
+7.90M
--
Sep 26, 2025
LWY GROUP LTD
6.25M
6.51%
--
--
Feb 14, 2025
UBS Financial Services, Inc.
52.41K
0.05%
+30.05K
+134.37%
Jun 30, 2025
Citadel Advisors LLC
29.65K
0.03%
-19.92K
-40.18%
Jun 30, 2025
Susquehanna International Group, LLP
11.08K
0.01%
+11.08K
--
Jun 30, 2025
XTX Markets LLC
--
0%
-19.16K
-100.00%
Jun 30, 2025
Virtu Americas LLC
--
0%
-40.01K
-100.00%
Mar 31, 2025
HRT Financial LP
--
0%
-23.60K
-100.00%
Mar 31, 2025
Scientech Research LLC
--
0%
-15.75K
-100.00%
Mar 31, 2025
Two Sigma Investments, LP
--
0%
-11.39K
-100.00%
Jun 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI